Leadership
Dr Mark Dale
Chairman and CEO
Dr Mark Dale is the CEO of CliniSafe. Dr Dale has extensive experience in the international clinical trials sector at Phase I through Phase IV, and is a specialist in clinical trial consultancy, protocol design and implementation. Dr Dale is a frequent consultant to industry and has been author to numerous peer reviewed articles in neuropsychiatry and clinical trials. Dr Dale obtained his MBCHB in Medicine from the University of Manchester and is a member of the Royal College of Psychiatrists. His entrepreneurial flair has been recognized by numerous awards including a prestigious Institute of Directors Award for Innovation. He is the inventor of CliniSafe, voted SCRIP’s “Best Technological Development in Clinical Trials” in 2010.
Vision Mission Culture
Our Vision is to prevent and eliminate inappropriate prescribing of concomitant medications to subjects in clinical trials.
Our Mission is that globally, all healthcare professionals will have access to our electronic system to protect the subjects they enroll into clinical trials.
Our Culture encompasses Quality, Safety, Service and Teamwork.
Meet the Team
Steve Higham
Chief Operating Officer
Roger Cope
Quality Manager
Paul Jenkins
Head of Business Development
Anthony Osei - Agyemang
Developer